Transvascular methods of treating extravascular tissue

Patent metadata

Field	Value
Publication number	US-9539047-B2
Application number	US-201514932128-A
Country	US
Kind code	B2
Filing date	Nov 4, 2015
Priority date	Oct 29, 2012
Publication date	Jan 10, 2017
Grant date	Jan 10, 2017

Abstract

An intravascular catheter for peri-vascular or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand with open ends around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, such as nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. The system also includes controls the depth of penetration of the ablative fluid into and beyond the tissue of the vessel wall. The preferred embodiment of the catheter includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened injection needles are advanced to penetrate into the vessel wall.

First claim

What is claimed is:

1. A method for ablating tissue that is located radially outward from an interior surface of an interior wall of a target vessel of a human body, the method including:
providing a tissue ablation catheter having a proximal end and a distal end, the tissue ablation catheter comprising three or more needle guiding elements through which three or more injection needles are advanced, the three or more needle guiding elements and the three or more injection needles being located at a distal portion of the tissue ablation catheter;
advancing the distal portion of the tissue ablation catheter to a site within the target vessel where tissue ablation is to be performed;
advancing the three or more needle guiding elements to expand outwardly against the interior surface of the target vessel;
advancing the three or more injection needles through the three or more guiding elements and into the interior wall of the target vessel; and
injecting an ablative fluid through the three or more injection needles into an adventitia of the target vessel creating three or more ablative fluid zones, wherein the ablative fluid zones intersect to form an ablation ring around the circumference of, and outside the interior surface of the target vessel; and wherein the ablative fluid is injected in a region that is more than 2 mm beyond the interior surface of the target vessel.

2. The method of claim 1 , wherein the three or more needle guiding elements are advanced through openings in a side wall of the tissue ablation catheter.

3. The method of claim 1 , where the target vessel is a pulmonary vein.

4. The method of claim 1 , further including retracting the three or more injection needles that have been advanced after injecting the ablative fluid.

5. The method of claim 4 , wherein the three or more injection needles can be completely withdrawn within the tissue ablation catheter to prevent needlestick injuries.

6. The method of claim 1 , further including retracting the three or more needle guiding elements that have been advanced after injecting the ablative fluid.

7. The method of claim 1 , further including removing the tissue ablation catheter from the target vessel.

8. The method of claim 1 , wherein advancing the three or more needle guiding elements centers the distal portion of the tissue ablation catheter within the target vessel.

9. The method of claim 1 , wherein injecting the ablative fluid comprises injecting ethanol.

10. The method of claim 1 , wherein the target vessel is a renal artery.

11. The method of claim 1 , wherein injecting the ablative fluid through the three or more injection needles further includes injecting between 0.1 and 5 ml of ablative fluid.

12. A method for ablating tissue that is located radially outward from an interior surface of an interior wall of a target vessel of a human body, the method including:
providing a tissue ablation catheter having a proximal end and a distal end, the tissue ablation catheter comprising three or more needle guiding elements through which three or more injection needles are advanced, the three or more needle guiding elements and the three or more injection needles being located at a distal portion of the tissue ablation catheter;
advancing the distal portion of the tissue ablation catheter to a site within the renal artery where tissue ablation is to be performed;
advancing the three or more needle guiding elements to expand outwardly against the interior surface of the renal artery;
advancing the three or more injection needles through the three or more guiding elements and into the interior wall of the renal artery; and
injecting an ablative fluid through the three or more injection needles into an adventitia of the renal artery creating three or more ablative fluid zones, wherein the ablative fluid zones intersect to form an ablation ring around the circumference of, and outside the interior surface of the renal artery; and wherein the ablative fluid is injected in a region that is more than 1 mm beyond the interior surface of the renal artery.

13. The method of claim 12 , wherein the three or more needle guiding elements are advanced through openings in a side wall of the tissue ablation catheter.

14. The method of claim 12 , further including retracting the three or more injection needles that have been advanced.

15. The method of claim 14 , wherein the three or more injection needles can be completely withdrawn within the tissue ablation catheter to prevent needlestick injuries.

16. The method of claim 12 , further including retracting the three or more needle guiding elements that have been advanced.

17. The method of claim 12 , further including removing the tissue ablation catheter from the renal artery.

18. The method of claim 12 , wherein advancing the three or more needle guiding elements centers the distal portion of the tissue ablation catheter within the renal artery.

19. The method of claim 12 , wherein injecting the ablative fluid further comprises injecting ethanol.

20. The method of claim 12 , wherein injecting the ablative fluid through the three or more injection needles further includes injecting between 0.1 and 5 ml of ablative fluid.

Assignees

• Ablative Solutions Inc

Inventors

• Fischell David R
• Fischell Tim A
• Ragland Robert Ryan
• Kent Darrin James
• Denison Andy Edward
• Johnson Eric Thomas
• Burke Jeff Alan
• Hayden Christopher Scott

Classifications

• A61B90/39

  Markers, e.g. radio-opaque or breast lesions markers · CPC title

• A61B2018/046

  in liquid form · CPC title

• A61B2090/3966

  Radiopaque markers visible in an X-ray image · CPC title

• A61B2018/00404

  Blood vessels other than those in or around the heart · CPC title

• A61M25/1002

  characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence) · CPC title